115 related articles for article (PubMed ID: 37949354)
1. Patient Preferences in Pulmonary Arterial Hypertension, a Latent Class Analysis to Identify Preference Heterogeneity.
Mühlbacher A; Beaudet A; Brand M; Janssen EM; Gunz H; Li W; Preiss M; Sadler A; DiSantostefano RL
Value Health; 2024 Feb; 27(2):206-215. PubMed ID: 37949354
[TBL] [Abstract][Full Text] [Related]
2. Parental preferences for vesicoureteral reflux treatment: Profile case best-worst scaling.
Dionise ZR; Gonzalez JM; Garcia-Roig ML; Kirsch AJ; Scales CD; Wiener JS; Purves JT; Routh JC
J Pediatr Urol; 2021 Feb; 17(1):86.e1-86.e9. PubMed ID: 33309608
[TBL] [Abstract][Full Text] [Related]
3. Heterogeneity in Preferences for Anti-coagulant Use in Atrial Fibrillation: A Latent Class Analysis.
van Til J; Oudshoorn-Groothuis C; Weernink M; von Birgelen C
Patient; 2020 Aug; 13(4):445-455. PubMed ID: 32329020
[TBL] [Abstract][Full Text] [Related]
4. Patient preferences do matter: a discrete choice experiment conducted with breast cancer patients in six European countries, with latent class analysis.
Stamuli E; Corry S; Foss P
Int J Technol Assess Health Care; 2023 Apr; 39(1):e21. PubMed ID: 37074007
[TBL] [Abstract][Full Text] [Related]
5. Comparing Outcomes of a Discrete Choice Experiment and Case 2 Best-Worst Scaling: An Application to Neuromuscular Disease Treatment.
Soekhai V; Donkers B; Johansson JV; Jimenez-Moreno C; Pinto CA; de Wit GA; de Bekker-Grob E
Patient; 2023 May; 16(3):239-253. PubMed ID: 36781628
[TBL] [Abstract][Full Text] [Related]
6. Patients' Preferences for Systemic Lupus Erythematosus Treatments-A Discrete Choice Experiment.
Collacott H; Phillips-Beyer A; Krucien N; Flamion B; Marsh K
Patient; 2024 May; 17(3):287-300. PubMed ID: 38270788
[TBL] [Abstract][Full Text] [Related]
7. Exploring patient preference heterogeneity for pharmacological treatments for chronic pain: A latent class analysis.
Walsh DA; Boeri M; Abraham L; Atkinson J; Bushmakin AG; Cappelleri JC; Hauber B; Klein K; Russo L; Viktrup L; Turk D
Eur J Pain; 2022 Mar; 26(3):648-667. PubMed ID: 34854164
[TBL] [Abstract][Full Text] [Related]
8. Preferences for Monitoring Comprehensive Heart Failure Care: A Latent Class Analysis.
Mühlbacher AC; Sadler A; Juhnke C
Patient; 2024 Jan; 17(1):83-95. PubMed ID: 38017336
[TBL] [Abstract][Full Text] [Related]
9. Heterogeneous Patient Preferences for Modern Antiretroviral Therapy: Results of a Discrete Choice Experiment.
Ostermann J; Mühlbacher A; Brown DS; Regier DA; Hobbie A; Weinhold A; Alshareef N; Derrick C; Thielman NM
Value Health; 2020 Jul; 23(7):851-861. PubMed ID: 32762986
[TBL] [Abstract][Full Text] [Related]
10. Patient preferences in the treatment of hemophilia A: A latent class analysis.
Mühlbacher AC; Sadler A; Lamprecht B; Juhnke C
PLoS One; 2021; 16(8):e0256521. PubMed ID: 34424920
[TBL] [Abstract][Full Text] [Related]
11. [Risk factors for death and the clinical features of different subtypes of patients with pulmonary arterial hypertension related to congenital heart disease].
Xu ZY; Li QQ; Zhang C; Zhang HS; Gu H
Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Apr; 48(4):315-322. PubMed ID: 32370483
[No Abstract] [Full Text] [Related]
12. Patients' Preferences for Artificial Intelligence Applications Versus Clinicians in Disease Diagnosis During the SARS-CoV-2 Pandemic in China: Discrete Choice Experiment.
Liu T; Tsang W; Huang F; Lau OY; Chen Y; Sheng J; Guo Y; Akinwunmi B; Zhang CJ; Ming WK
J Med Internet Res; 2021 Feb; 23(2):e22841. PubMed ID: 33493130
[TBL] [Abstract][Full Text] [Related]
13. Understanding patients' preferences for osteoporosis treatment: the impact of patients' characteristics on subgroups and latent classes.
Cornelissen D; Boonen A; Bours S; Evers S; Dirksen C; Hiligsmann M
Osteoporos Int; 2020 Jan; 31(1):85-96. PubMed ID: 31606825
[TBL] [Abstract][Full Text] [Related]
14. Patient preferences for community pharmacy asthma services: a discrete choice experiment.
Naik-Panvelkar P; Armour C; Rose JM; Saini B
Pharmacoeconomics; 2012 Oct; 30(10):961-76. PubMed ID: 22823521
[TBL] [Abstract][Full Text] [Related]
15. Public Preference Heterogeneity and Predicted Uptake Rate of Upper Gastrointestinal Cancer Screening Programs in Rural China: Discrete Choice Experiments and Latent Class Analysis.
Liu R; Li Q; Li Y; Wei W; Ma S; Wang J; Zhang N
JMIR Public Health Surveill; 2023 Jul; 9():e42898. PubMed ID: 37428530
[TBL] [Abstract][Full Text] [Related]
16. Quantifying Benefit-Risk Preferences for Heart Failure Devices: A Stated-Preference Study.
Reed SD; Yang JC; Rickert T; Johnson FR; Gonzalez JM; Mentz RJ; Krucoff MW; Vemulapalli S; Adamson PB; Gebben DJ; Rincon-Gonzalez L; Saha A; Schaber D; Stein KM; Tarver ME; Bruhn-Ding D
Circ Heart Fail; 2022 Jan; 15(1):e008797. PubMed ID: 34937393
[TBL] [Abstract][Full Text] [Related]
17. Enhanced External Counterpulsation (EECP): An Evidence-Based Analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2006; 6(5):1-70. PubMed ID: 23074496
[TBL] [Abstract][Full Text] [Related]
18. Patient and General Population Preferences Regarding the Benefits and Harms of Treatment for Metastatic Prostate Cancer: A Discrete Choice Experiment.
Menges D; Piatti MC; Omlin A; Cathomas R; Benamran D; Fischer S; Iselin C; Küng M; Lorch A; Prause L; Rothermundt C; O'Meara Stern A; Zihler D; Lippuner M; Braun J; Cerny T; Puhan MA
Eur Urol Open Sci; 2023 May; 51():26-38. PubMed ID: 37187724
[TBL] [Abstract][Full Text] [Related]
19. Population Preferences for Primary Care Models for Hypertension in Karnataka, India.
Leslie HH; Babu GR; Dolcy Saldanha N; Turcotte-Tremblay AM; Ravi D; Kapoor NR; Shapeti SS; Prabhakaran D; Kruk ME
JAMA Netw Open; 2023 Mar; 6(3):e232937. PubMed ID: 36917109
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
